IMPORTANT COVID INFORMATION: In an effort to ensure safety for our attendees and staff, this conference will be requiring attendees to show proof of COVID-19 vaccination at the conference. The conference will also be providing mandatory rapid COVID-19 testing upon arrival, prior to entering the event.
2022 FEATURED KEYNOTE SPEAKER:
BUILDING INNOVATIVE PLATFORM COMPANIES AND MEDICINES:
AN ACADEMIC’S REFLECTIONS
BENJAMIN F. CRAVATT
Professor and the Norton B. Gilula Chair of Chemical Biology in the Department of Chemistry at The Scripps Research Institute
His research group is interested in developing chemical proteomic technologies that enable protein and drug discovery on a global scale and applying these methods to characterize biochemical pathways that play important roles in human physiology and disease, especially as pertains to the nervous system and cancer.
His honors include a Searle Scholar Award, the Eli Lilly Award in Biological Chemistry, a Cope Scholar Award, the ASBMB Merck Award, the RSC Jeremy Knowles Award, and memberships in the American Academy of Arts and Sciences, National Academy of Medicine, and National Academy of Sciences.
Dr. Cravatt is an Associate Editor for JACS and is a co-founder of Activx Biosciences, Abide Therapeutics, and Vividion Therapeutics.